NasdaqGS:KLRABiotechs
Kailera Therapeutics IPO And Governance Shift Draw Investor Attention
Kailera Therapeutics, NasdaqGS:KLRA, completed its initial public offering and began trading as a public company.
The company implemented a restated certificate of incorporation and amended bylaws that adjust board structure, shareholder rights, and forum selection.
Kailera Therapeutics was added to the NASDAQ Composite Index, increasing its visibility among index-tracking investors.
With NasdaqGS:KLRA now trading at $25.15, Kailera Therapeutics has moved into the public markets with fresh...